News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TradingKey Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Amarin Corporation PLC's Q1 2025 earnings call transcript reveals mixed results. The company achieved significant progress in extending European IP protection, expanding global presence for VESCEPA, and maintaining a debt-free balance sheet. However, total net revenue and U.S. product revenue declined due to generic …
Amarin Corporation's SVP & CFO, Peter L. Fishman, reported equity compensation activity where 313 Restricted Stock Units vested and converted into American Depositary Shares (ADSs). To cover tax obligations, 155 ADSs were withheld by the company at $14.26 per share, a transaction noted as …
Amarin reported its Q2 2026 results, showing total net revenue of $42.2 million, gross profit of $14.99 million, and a narrowed GAAP net loss of $7.7 million. The company generated positive cash flow and held $314.6 million in cash, driven by rising in-market demand …
Amarin Corp PLC reported its Q2 2026 earnings, showcasing strategic growth in international markets despite an overall revenue decrease to $42.2 million from $72.7 million year-over-year. The company highlighted successful dual commercial strategies, including significant international expansion of VASCEPA, and improved its cash position …
Amarin (NASDAQ: AMRN) reported Q2 2026 financial results with total net revenue of $42.2 million, a 42% year-over-year decrease primarily due to the absence of a prior-year upfront payment. Despite this, the company saw a 59% rise in global in-market demand for VASCEPA/VAZKEPA, with …
AMARIN CORP PLC/UK reported Q2 2026 revenue of $42.2M, a significant decrease from $72.7M in the prior year, primarily due to lower licensing and royalty receipts post a prior-year upfront payment. Despite a decline in overall revenue, U.S. product revenue saw modest growth due …
Amarin Corporation Plc reported significantly reduced operating expenses in Q2 2026 following the completion of a $70 million annual cost-savings program and restructuring initiatives. Despite a decline in total net revenue due to the absence of a prior-year licensing payment, the company narrowed its …
Amarin Corporation reported a 42% year-over-year decrease in second-quarter net revenue, primarily due to the absence of a $25 million licensing payment received from Recordati in the prior year. Despite the revenue drop, the company's operating expenses fell by 59% due to cost-saving initiatives, …
Amarin Corp. (AMRN) announced its second-quarter earnings, reporting an in-line EPS of $0.00. The company's revenue for the quarter reached $42.2 million. This financial update provides key figures for investors interested in Amarin's recent performance.
This article provides an earnings snapshot for Amarin's Q2 performance. It is a very brief announcement, indicating that the company's Q2 earnings were in line with expectations.
This article provides fundamental and financial data for Amarin Corp - ADR (AMRN). It details current stock metrics such as market capitalization, current price, PE ratio, dividend yield, and 52-week high/low. The page also includes recent news headlines related to pharmaceutical companies and discussions …
This page provides current stock information for Amarin Corp (AMRN), including its latest stock price, market capitalization, volume, and upcoming earnings date. It also lists recent financial news related to other pharmaceutical companies and trending stock discussions. The stock is currently trading at $13.69, …
Amarin Corporation's EVP and Chief Scientific Officer, Steven B. Ketchum, reported recent equity activity. On July 1, 2026, he acquired 3,688 American Depositary Shares (ADS) from restricted stock unit vesting, while 1,887 ADS were withheld to cover tax obligations. Following these transactions, Ketchum directly …
Amarin (NASDAQ: AMRN) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, before market open. This will be followed by a conference call with senior management at 8:00 a.m. ET. Investors can access the live call via telephone …
Amarin Corporation's SVP & CFO, Peter L. Fishman, acquired 2,447 American Depositary Shares (ADS) on July 1, 2026, through an equity award vesting from the 2020 Stock Incentive Plan. The company withheld 1,206 ADS at $15.94 per ADS to cover taxes, which was not …
David Paul Keenan, EVP and Chief Operating Officer of Amarin Corporation (AMRN), reported recent equity compensation activities. This included the vesting of 3,688 Restricted Stock Units (RSUs) linked to American Depositary Shares (ADSs) and the withholding of 1,926 ADSs to cover tax obligations. Following …
Jonathan Provoost, EVP and Chief Legal Officer of Amarin Corporation, reported RSU activity where he acquired 3,688 American Depositary Shares (ADS) and had 1,264 ADS withheld for tax obligations, which is not considered a market sale. This activity relates to a 7,376-unit RSU grant …
Amarin Corporation plc (NASDAQ: AMRN) has announced that it will release its second quarter 2026 financial results and host a conference call on Wednesday, July 29, 2026. The company will issue a press release before market hours, followed by a call with senior management …
Search by ticker symbol or company name and select a result to open its chart.